-
Rhyddhawyd ar: 08 September 2022
|
Bwletin ystadegol
An analysis of the socio-demographic characteristics associated with the risk of coronavirus (COVID-19) death in boosted individuals in England.
-
Rhyddhawyd ar: 10 March 2023
|
Setiau data
Findings from the Coronavirus (COVID-19) Infection Survey for England.
-
Rhyddhawyd ar: 17 July 2020
|
Setiau data
Number of deaths registered each month in England and Wales, including deaths involving the coronavirus (COVID-19), by age, sex and country.
-
Rhyddhawyd ar: 07 May 2020
|
Setiau data
The indicators and analysis presented in this bulletin are based on responses from the new voluntary fortnightly business survey, which captures businesses responses on how their turnover, workforce prices, trade and business resilience have been affected in the two week reference period. These data relate to the period 6 April 2020 to 19 April 2020.
-
Rhyddhawyd ar: 10 March 2023
|
Setiau data
Findings from the Coronavirus (COVID-19) Infection Survey for Wales.
-
Rhyddhawyd ar: 21 April 2022
|
Setiau data
Analysis of populations in the UK by likelihood of having received a third vaccination against COVID-19 using the Coronavirus (COVID-19) Infection Survey. This survey is being delivered in partnership with University of Oxford, University of Manchester, UK Health Security Agency and Wellcome Trust.
-
Rhyddhawyd ar: 12 June 2020
|
Setiau data
Provisional counts of the number of deaths and age-standardised mortality rates (ASMRs) involving the coronavirus (COVID-19) between 1 March and 30 April 2020 in the UK.
-
Rhyddhawyd ar: 10 March 2023
|
Setiau data
Findings from the Coronavirus (COVID-19) Infection Survey for Scotland.
-
Rhyddhawyd ar: 27 September 2021
|
Setiau data
Populations in the UK by risk of testing positive for COVID-19 from the Coronavirus (COVID-19) Infection Survey.
-
Rhyddhawyd ar: 16 December 2020
|
Setiau data
Experimental estimates of the prevalence and duration of long COVID symptoms, and rates of adverse events for hospitalised coronavirus (COVID-19) patients compared with those for matched control patients.
